<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00770666</url>
  </required_header>
  <id_info>
    <org_study_id>0220055373</org_study_id>
    <nct_id>NCT00770666</nct_id>
  </id_info>
  <brief_title>Combination Medications vs. Patch Alone for Medically-Ill Smokers</brief_title>
  <official_title>Flexibly-Dosed Combination Pharmacotherapy Versus Standard-Dosed Nicotine Patch Alone for Smokers With Medical Illness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Medicine and Dentistry of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rutgers Cancer Institute of New Jersey</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Robert Wood Johnson Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized clinical trial to evaluate a flexibly-dosed-3-medication combination for up to 6
      months in smokers with medical illness
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects randomly received either nicotine patch alone for a 10-week, tapering course (n=64)
      or the combination of nicotine patch, nicotine oral inhaler, and bupropion for an ad-lib
      duration (n=63).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tobacco use abstinence</measure>
    <time_frame>26 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first relapse</measure>
    <time_frame>varies</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of medication use</measure>
    <time_frame>26 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse clinical events</measure>
    <time_frame>26 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">127</enrollment>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nicotine patch, nicotine inhaler, bupropion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nicotine patch</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine patch, nicotine inhaler, bupropion</intervention_name>
    <description>Patch - 21 mg - taper as able Inhaler - as needed Bupropion SR 150 mg daily</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine patch</intervention_name>
    <description>21 mg daily for 6 weeks followed by 14 mg for 2 weeks and then 7 mg for 2 weeks</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  currently smoking at least 10 cigarettes per day (confirmed by high exhaled
             carbon-monoxide (CO))

          -  18 years or older

          -  interested in quitting within the next 30 days

          -  one or more pre-defined medical illnesses (including cardiovascular disease, other
             vascular disease, chronic pulmonary disease, cancer, hypertension, diabetes,
             hyperlipidemia, and recurrent pulmonary infections)

        Exclusion Criteria:

          -  contraindications to pharmacotherapy (including unstable angina, myocardial infarction
             within 2 months, severe arrhythmia, seizure disorder, serious mental illness requiring
             antipsychotic medications)

          -  current use of other tobacco products (smokeless tobacco, cigars, pipes, etc.),
             bupropion, clonidine, nortriptyline, or nicotine replacement medications

          -  unable to give consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael B Steinberg, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMDNJ-RWJMS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Umdnj-Rwjms</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2008</study_first_submitted>
  <study_first_submitted_qc>October 9, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2008</study_first_posted>
  <last_update_submitted>October 9, 2008</last_update_submitted>
  <last_update_submitted_qc>October 9, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2008</last_update_posted>
  <responsible_party>
    <name_title>Michael Steinberg, MD, MPH</name_title>
    <organization>UMDNJ-Robert Wood Johnson Medical School</organization>
  </responsible_party>
  <keyword>Tobacco dependence treatment</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
    <mesh_term>Bupropion</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

